{"DataElement":{"publicId":"5096026","version":"1","preferredName":"Thrombotic Microangiopathy Sign or Symptom Present Type","preferredDefinition":"A description of the thrombotic microangiopathy sign or symptom that was present.","longName":"5096030v1.0:5095980v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5096030","version":"1","preferredName":"Thrombotic Microangiopathy Sign or Symptom Present","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation._Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom)._Being or existing in a specified place or at the specified time.","longName":"5096028v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5096028","version":"1","preferredName":"Thrombotic Microangiopathy Sign or Symptom","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.:Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C62605:C100104","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombotic Microangiopathy","conceptCode":"C62605","definition":"A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sign or Symptom","conceptCode":"C100104","definition":"Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"288729C9-B539-218D-E050-BB89AD434F9B","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"ONEDATA","dateModified":"2016-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"288729C9-B547-218D-E050-BB89AD434F9B","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5095980","version":"1","preferredName":"Thrombotic Microangiopathy Sign or Symptom Type","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation._Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom)._Something distinguishable as an identifiable class based on common qualities.","longName":"5095980v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Neurologic dysfunction without other explanation","valueDescription":"Neurological Deficit or Dysfunction Without Other Explanation","ValueMeaning":{"publicId":"5097070","version":"1","preferredName":"Neurological Deficit or Dysfunction Without Other Explanation","longName":"5097070","preferredDefinition":"A finding of pathologic function within the central or peripheral nervous system, secondary to developmental abnormalities, infections, neurologic damage, or tumors.: Used to indicate the absence or lack of something or someone.: Different than the one(s) previously specified or mentioned.: A set of statements describing a group of facts that clarifies the cause, context and/or consequence of those facts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurological Deficit or Dysfunction","conceptCode":"C50672","definition":"A finding of pathologic function within the central or peripheral nervous system, secondary to developmental abnormalities, infections, neurologic damage, or tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Explanation","conceptCode":"C86073","definition":"A set of statements describing a group of facts that clarifies the cause, context and/or consequence of those facts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF86F0-8385-087D-E050-BB89AD436321","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF86F0-839E-087D-E050-BB89AD436321","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"Increased serum LDH above institutional baseline","valueDescription":"Increase Serum Lactate Dehydrogenase Measurement Above Institution Baseline","ValueMeaning":{"publicId":"5097068","version":"1","preferredName":"Increase Serum Lactate Dehydrogenase Measurement Above Institution Baseline","longName":"5097068","preferredDefinition":"A process of becoming larger, more numerous, more important, or more likely.: The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.: A quantitative measurement of the amount of lactate dehydrogenase present in a sample.: In a place or position that is higher.: An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.: A starting point to which things may be compared.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Lactate Dehydrogenase Measurement","conceptCode":"C64855","definition":"A quantitative measurement of the amount of lactate dehydrogenase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Above","conceptCode":"C75329","definition":"In a place or position that is higher.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Institution","conceptCode":"C41206","definition":"An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF86F0-8335-087D-E050-BB89AD436321","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF86F0-834E-087D-E050-BB89AD436321","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"Renal dysfunction without other explanation","valueDescription":"Renal Failure Without Other Explanation","ValueMeaning":{"publicId":"5097069","version":"1","preferredName":"Renal Failure Without Other Explanation","longName":"5097069","preferredDefinition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.: Used to indicate the absence or lack of something or someone.: Different than the one(s) previously specified or mentioned.: A set of statements describing a group of facts that clarifies the cause, context and/or consequence of those facts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Explanation","conceptCode":"C86073","definition":"A set of statements describing a group of facts that clarifies the cause, context and/or consequence of those facts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF86F0-835D-087D-E050-BB89AD436321","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF86F0-8376-087D-E050-BB89AD436321","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"RBC fragmentation and >2 schistocytes per high-power field on peripheral smear","valueDescription":"Greater Than Two Schistocyte Count High Power Field Blood Smear","ValueMeaning":{"publicId":"5097071","version":"1","preferredName":"Greater Than Two Schistocyte Count High Power Field Blood Smear","longName":"5097071","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: A measurement of the schistocytes (fragmented red blood cells) in a biological specimen.: The area visible under the maximum magnification power of the objective being used in microscopy.: A sample of blood applied in a thin film to a microscope slide for study under a microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Schistocyte Count","conceptCode":"C74706","definition":"The determination of the number of schistocytes present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"High Power Field","conceptCode":"C67274","definition":"The area visible under the maximum magnification power of the objective being used in microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Blood Smear","conceptCode":"C79903","definition":"A sample of blood applied in a thin film to a microscope slide for study under a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF86F0-83AE-087D-E050-BB89AD436321","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF86F0-83F3-087D-E050-BB89AD436321","beginDate":"2016-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"Negative direct and indirect Coombs test results","valueDescription":"Negative Finding Direct Antiglobulin Test And Indirect Antiglobulin Test Outcome","ValueMeaning":{"publicId":"5096025","version":"1","preferredName":"Negative Finding Direct Antiglobulin Test And Indirect Antiglobulin Test Outcome","longName":"5096025","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.: The result of an action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Direct Antiglobulin Test","conceptCode":"C81974","definition":"A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indirect Antiglobulin Test","conceptCode":"C91372","definition":"A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2886F8A8-F8E3-F3A3-E050-BB89AD431CDE","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2886F8A8-F8FC-F3A3-E050-BB89AD431CDE","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"ONEDATA","dateModified":"2016-01-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5095979","version":"1","preferredName":"Thrombotic Microangiopathy Sign or Symptom Type","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.:Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).:Something distinguishable as an identifiable class based on common qualities.","longName":"C62605:C100104:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombotic Microangiopathy","conceptCode":"C62605","definition":"A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign or Symptom","conceptCode":"C100104","definition":"Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2886F8A8-F86F-F3A3-E050-BB89AD431CDE","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"ONEDATA","dateModified":"2016-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2886F8A8-F880-F3A3-E050-BB89AD431CDE","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_OF_tma_sign_symp_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the thrombotic micro","type":"Preferred Question Text","description":"What was the thrombotic microangiopathy sign or symptom?","url":null,"context":"NHLBI"},{"name":"Specify signs and symptoms","type":"Alternate Question Text","description":"Specify signs and symptoms","url":null,"context":"NHLBI"},{"name":"Specify signs and symptoms","type":"Application Standard Question Text","description":"Specify signs and symptoms","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"288729C9-B506-218D-E050-BB89AD434F9B","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"MALUMK","dateModified":"2021-10-04","changeDescription":".Added missing ASQT. 06/29/2021 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}